Description: The study sought to explore novel genetic aberration driving squamous cell lung carcinoma (LUSC). The whole exome (WES), whole genome (WGS) and target region (TS) sequencings and CRISPR-Cas9 genome editing techniques were integrated to explore and validate novel targeting candidates from LUSC primary tumors and corresponding patient-derived xenografts (PDXs).

Data type: Genome sequencing

Sample scope: Monoisolate

Release date: 2022-06-29

Last updated: 2019-01-21

Data size: 3.38TB